Evidence map›Paper›PMID 41503802›Full record

ArticleChemistry & biodiversity2026

Design, Synthesis, and Anti-Inflammatory Activity of Functionalized 1,2,4,5-Tetrasubstituted-Pyrimidinone.

Rayees Ahmad Naikoo, Diljeet Kumar, Nusrit Iqbal Andrabi, Yassir Arfath, Hemender Singh, Rupesh Kumar, Zabeer Ahmed, Gaurav Bhargava

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rayees Ahmad NaikooDepartment of Chemical Sciences, I.K. Gujral Punjab Technical University, Kapurthala, India.
Diljeet KumarPharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Nusrit Iqbal AndrabiPharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Yassir ArfathPharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Hemender SinghSchoolof Biotechnology, Shri Mata Vashino Devi University, Katra, India.
Rupesh KumarDepartment of Chemical Sciences, I.K. Gujral Punjab Technical University, Kapurthala, India.
Zabeer AhmedPharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Gaurav BhargavaDepartment of Chemical Sciences, I.K. Gujral Punjab Technical University, Kapurthala, India.ORCID https://orcid.org/0000-0001-9128-8596

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A highly efficient aza-Michael addition reaction of 5-amino pyrimidinones with α, β-unsaturated olefins under optimized reaction conditions is reported. The resulting functionalized amino-pyrimidinone-based aza-Michael mono-adducts were obtained in good to excellent yields. These synthesized compounds were screened for their anti-inflammatory potential in RAW264.7 macrophages. Among the synthesized compounds, we identified two derivatives, 3d and 3f, as potent anti-inflammatory compounds. Our findings demonstrated that 3d and 3f maintained normal cell viability at the bioactive concentrations (1, 5, and 10 µM), effectively reduced the production of proinflammatory mediators such as nitric oxide and proinflammatory cytokines including interleukin-6 and tumor necrosis factor-α. In addition, immunoblotting results revealed that 3d and 3f downregulate the protein expression of i-NOS and COX-2 in LPS-activated RAW264.7 macrophages. Furthermore, molecular docking was performed to elucidate the binding mechanism of these compounds and to establish a correlation between the in vitro results and the in silico data. Collectively, our results suggest that 3d and 3f attenuated the LPS-induced inflammatory response in macrophages and can be a structural lead for the development of novel anti-inflammatory agents.

Indexed as

Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalDrug DesignPyrimidinonesAnimalsCell SurvivalCyclooxygenase 2Dose-Response Relationship, DrugInterleukin-6LipopolysaccharidesMacrophagesMiceMolecular Docking SimulationMolecular StructureNitric OxideRAW 264.7 CellsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2Interleukin-6LipopolysaccharidesNitric OxidePyrimidinonesTumor Necrosis Factor-alphaamino pyrimidinonesanti‐inflammatory potentialaza‐Michael additionα,β‐unsaturated olefinsβ‐amino carbonyl compounds

Identifiers

PMID41503802
PMCPMC13419928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.